Sign in

Hormone Replacement Therapy Market Is Estimated To Witness High Growth Owing To Opportunity Of Rising Menopausal Population

Hormone Replacement Therapy Market Is Estimated To Witness High Growth Owing To Opportunity Of Rising Menopausal Population

Hormone Replacement Therapy (HRT) helps treat symptoms of menopause by replacing hormones that are diminished during menopause. It is effective in treating hot flashes, night sweats, and vaginal dryness in women. With the increasing average age of women experiencing menopause, the demand for treating related symptoms is rising substantially. The global Hormone Replacement Therapy Market is estimated to be valued at US$ 7.5 billion in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023.

Market Opportunity:

The rising menopausal population presents a key opportunity for growth in the Hormone Replacement Therapy Market. According to estimates, approximately 1.3 billion women globally will experience menopause by the year 2025. Moreover, increasing healthcare awareness about treatment of menopause symptoms and growth of women healthcare services are contributing significantly to this large population. As symptoms for long-term like hot flashes, night sweats, and mood swings negatively impact quality of life, more women are opting for HRT for effective management of menopause. This rising menopausal population experiencing symptoms over longer lifespans creates enormous opportunities for HRT products to cater to this growing demand. The market players can expand availability of customized and new product offerings to benefit from this major opportunity of target population growth.

Porter's Analysis

Threat of new entrants: The threat of new entrants in the hormone replacement therapy market is low as it requires huge capital investment and regulatory approvals to enter this market. Additionally, established players have strong brand recognition and supply chain which create entry barriers.

Bargaining power of buyers: The bargaining power of buyers in this market is high. Buyers can opt for generic drugs which are cheaper than branded drugs. Additionally, there are many players operating in this market giving buyers options to switch between brands.

Bargaining power of suppliers: The bargaining power of suppliers is moderate. Few players dominate the supply of active ingredients for hormone replacement therapies. However, established players can develop alternate sources to negotiate better prices.

Threat of new substitutes: The threat of substitutes is moderate. Some alternative therapies like lifestyle changes, herbal remedies pose threat. However, their efficacy is still lower than hormone replacement therapies.

Competitive rivalry: The competitive rivalry is high due to presence of many global and local players. Players resort to intensive marketing activities and competitive pricing to gain market share.

SWOT Analysis

Strength: Hormone replacement therapy is an effective treatment for reducing menopause symptoms. It reduces the risk of osteoporosis and improves quality of life.

Weakness: Long term usage of hormone therapies may increase risk of breast cancer, heart disease and stroke. They are also not advised for women having history of hormone-sensitive cancers.

Opportunity: Growth opportunities exist in emerging markets due to improving access to healthcare facilities. Increasing awareness about menopause management supplements market growth.

Threats: Stringent regulations for approval and monitoring of hormone therapies increases costs. Social stigma around usage of hormones by aging women in developing regions hinders market growth.

Key Takeaways

The global Hormone Replacement Therapy MARKET Trends is expected to witness high growth during the forecast period of 2023.

North America currently dominates the market due to supportive reimbursement policies and raising awareness about menopause management. However, Asia Pacific is expected to grow at fastest pace due to improving healthcare infrastructure and rising medical tourism in the region.

Key players operating in the hormone replacement therapy market are Pfizer, Novartis, Bayer, Eli Lilly, Merck & Co., Mylan Laboratories, and Allergan. These players are undertaking mergers and acquisitions to enhance their product portfolio and geographical presence.

For more insights, read- https://www.ukwebwire.com/hormone-replacement-therapy-market-trends-size-and-share-analysis/

For more details on the report, Read- https://cmiinfopiece.blogspot.com/2024/01/plant-based-meat-market-growth.html


Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more